sec filing
VA
NASDAQ · VANI
Vivani Medical, Inc.
Healthcare · Medical - Devices
$1.22
Down-$0.01 (-0.82%)
Updated Sep 17, 2026, 6:55 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 82.71M
- P/E ratio
- -3.21
- Dividend yield
- 0.00%
- 52-week range
- $0.92 – $1.66
- Volume
- 142.26K
- Avg. volume
- 301.05K
Price performance
VANI price history
1M range · 20 trading sessions · Daily adjusted prices
VANI closed at $1.22 after 20 trading sessions, down 12.23% for the selected period.
- Last close
- $1.22
- Period change
- -12.23%
- Period low
- $1.22
- Period high
- $1.49
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.23 | $1.24 | $1.215 | $1.22 | 142.26K |
| Sep 15, 2026 | $1.26 | $1.275 | $1.21 | $1.23 | 208.64K |
| Sep 14, 2026 | $1.26 | $1.2837 | $1.24 | $1.26 | 151.67K |
| Sep 11, 2026 | $1.25 | $1.29 | $1.24 | $1.27 | 249.37K |
| Sep 10, 2026 | $1.31 | $1.31 | $1.25 | $1.25 | 255.87K |
| Sep 9, 2026 | $1.36 | $1.36 | $1.315 | $1.315 | 283.25K |
| Sep 8, 2026 | $1.50 | $1.50 | $1.34 | $1.355 | 466.38K |
| Sep 4, 2026 | $1.40 | $1.515 | $1.38 | $1.49 | 477.25K |
| Sep 3, 2026 | $1.44 | $1.47 | $1.37 | $1.39 | 231.12K |
| Sep 2, 2026 | $1.37 | $1.45 | $1.37 | $1.42 | 143.17K |
| Sep 1, 2026 | $1.36 | $1.388 | $1.35 | $1.36 | 191.5K |
| Aug 31, 2026 | $1.44 | $1.48 | $1.37 | $1.39 | 208.21K |
| Aug 28, 2026 | $1.41 | $1.43 | $1.39 | $1.42 | 163.03K |
| Aug 27, 2026 | $1.42 | $1.42 | $1.395 | $1.40 | 86.72K |
| Aug 26, 2026 | $1.43 | $1.45 | $1.3701 | $1.415 | 215.68K |
| Aug 25, 2026 | $1.38 | $1.42 | $1.34 | $1.42 | 200.72K |
| Aug 24, 2026 | $1.40 | $1.415 | $1.3428 | $1.38 | 174.44K |
| Aug 21, 2026 | $1.44 | $1.44 | $1.365 | $1.38 | 104.74K |
| Aug 20, 2026 | $1.36 | $1.4229 | $1.36 | $1.41 | 108.34K |
| Aug 19, 2026 | $1.46 | $1.53 | $1.301 | $1.39 | 789.16K |
Latest VANI news
The latest Smart Investors Daily articles mentioning VANI.
Stock researchResearch & News · SEC Filings
Loading stock research…